The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Axicabtagene ciloleucel (axi-cel) in combination with rituximab (Rtx) for the treatment (Tx) of refractory large B-cell lymphoma (R-LBCL): Outcomes of the phase 2 ZUMA-14 study.
 
Paolo Strati
Consulting or Advisory Role - ADC Therapeutics; Genentech/Roche; TG Therapeutics
Research Funding - ALX Oncology; AstraZeneca
 
Lori Ann Leslie
Consulting or Advisory Role - Abbvie; AstraZeneca/Merck; BeiGene; Celgene/Bristol-Myers Squibb; Epizyme; Janssen/Pharmacyclics; Kite/Gilead; Merck; Seagen; TG Therapeutics
Speakers' Bureau - AstraZeneca; BeiGene; Celgene; Epizyme; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Seagen; TG Therapeutics
 
Parveen Shiraz
Research Funding - Kite, a Gilead Company; Orca Bio
 
L Elizabeth Budde
Consulting or Advisory Role - BeiGene; Kite/Gilead; Novartis; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck; MustangBio
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - Kite/Gilead; Roche/Genentech
 
Olalekan O. Oluwole
Consulting or Advisory Role - ADC Therapeutics; Bayer; Curio Science; Kite/Gilead; Legend Biotech; Novartis; Pfizer; Spectrum Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst)
 
Matthew Ulrickson
Consulting or Advisory Role - Gilead Sciences; Stemline Therapeutics
 
Aravind Ramakrishnan
Honoraria - Amgen; Cigna; Takeda
Consulting or Advisory Role - Amgen; Takeda
Speakers' Bureau - Takeda
 
Jennifer Sun
Employment - Kite, a Gilead Company
 
Rhine Shen
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite/Gilead
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
 
Justyna Kanska
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Peter McCroskery
Employment - Kite, a Gilead Company
 
Jinghui Dong
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - GliaCure/Tufts
Patents, Royalties, Other Intellectual Property - Patent US8598141 (Dec 03, 2013)
 
Marco Andreas Schupp
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Hairong Xu
Employment - Kite, a Gilead Company
 
Krish Patel
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Epizyme; Genentech; Kite, a Gilead company; Loxo/Lilly; Morphosys; Pharmacyclics; Seagen; TG Therapeutics
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Kite, a Gilead company; TG Therapeutics
Research Funding - Aptevo Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); Epizyme (Inst); Fate Therapeutics (Inst); Kite/Gilead (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); Nurix (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Xencor (Inst)